Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer.

Zhang, Tingwei; Wei, Yu; Hong, Boon Hao; Sumiyoshi, Takayuki; Ong, Enya Hui Wen; Zeng, Hao; Li, Yonghong; Ng, Chi-Fai; Pan, Jian; Fang, Bangwei; Wang, Beihe; Wu, Junlong; Wang, Hongkai; Akamatsu, Shusuke; Chua, Melvin Lee Kiang; Ye, Dingwei; Zhu, Yao

Zhang, Tingwei; Wei, Yu; Hong, Boon Hao; Sumiyoshi, Takayuki; Ong, Enya Hui Wen; Zeng, Hao; Li, Yonghong; Ng, Chi-Fai; Pan, Jian; Fang, Bangwei; Wang, Beihe; Wu, Junlong; Wang, Hongkai; Akamatsu, Shusuke; Chua, Melvin Lee Kiang; Ye, Dingwei; Zhu, Yao.

Affiliation

Zhang T; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Wei Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Hong BH; Shanghai Genitourinary Cancer Institute, Shanghai, China.
Sumiyoshi T; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Ong EHW; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zeng H; Shanghai Genitourinary Cancer Institute, Shanghai, China.
Li Y; Division of Medical Sciences, National Cancer Centre Singapore, Singapore.
Ng CF; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Pan J; Division of Medical Sciences, National Cancer Centre Singapore, Singapore.
Fang B; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Wang B; Department of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Wu J; Department of Surgery, and SH Ho Urology Center, Chinese University of Hong Kong, Hong Kong, Hong Kong.
Wang H; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Akamatsu S; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Chua MLK; Shanghai Genitourinary Cancer Institute, Shanghai, China.
Ye D; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhu Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

Clin Transl Med ; 13(9): e1411, 2023 09.

Article de En | MEDLINE | ID: mdl-37700486

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Nomogrammes Type d'étude: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limites: Humans / Male Langue: En Journal: Clin Transl Med Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google